Gamma interferon induces expression of Mad1 gene in mocrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis

Journal of Cellular Biochemistry

Volumn 72, Issue 2, 1999, Pages 232-241

  Dey, Arunangsu ^a   Kim, Leopold ^a   Li, Wei ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antiproliferation; Cytokine; Growth factor; Oncogene; Signal transduction; Tumor suppressor gene

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLIN D1; CYCLIN D2; GAMMA INTERFERON; MESSENGER RNA; THYMIDINE; TRITIUM;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; IMMEDIATE EARLY GENE; MACROPHAGE; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CLONING, MOLECULAR; INTERFERON TYPE II; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MITOGENS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TIME FACTORS;

ANIMALIA; TRITIUM;

EID: 0033555782     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990201)72:2<232::AID-JCB7>3.0.CO;2-0     Document Type: Article

References (49)

1. Ayer DE, Eisenman RN. 1993. A switch from Myc: Max to Mad: Max heterocomplexes accompanies monocyte/macrophace differentiation. Genes Dev 7:2110-2119.
2. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
3. Ayer DE, Laherty CD, Lawrence QA, Armstrong AP, Eisenman RE. 1996. Mad proteins contain a dominant transcription repression domain. Mol Cell Biol 16:5772-5781.
4. Bourette RP, Myles GM, Choi J-L, Rohrschneider LR. 1997. Sequential activation of phosphatidylinositol 3-kinase and phospholipase C-gamma 2 by the M-CSF receptor is necessary for differentiation signaling. EMBO J 16:5880-5893.
5. Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE, Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci USA 23:7673-7678.
6. Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Luscher B. 1995. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Oncogene 11:587-596.
7. Chen J, Willinham T, Margraf LR, Schreiber-Agus N, DePinho RA, Nisen PD. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumor cells. Nature Med 1:638-643.
8. Chin YE, Kitagawa M, Su WS, You ZH, Iwamoto Y, Fu XY. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibtior p21 WAF1/CIP1 mediated by STAT1. Science 272:719-722.
9. Cocks BJ, Vario G, Bodrug SE, Hamilton JA. 1992. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem 267:12307-12310.
10. Cultraro CM, Bino T, Segal S. 1997. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol Cell Biol 17:2353-2359.
11. Darnell JE, Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
12. Darnell JE, Jr, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellualr signaling proteins. Science 264: 1415-1421.
13. De Maeyer E, De Maeyer-Guignard J. 1988. Macrophages as Interferon producers and interferons as modulators of macrophage activity. In: Interferons and other regulatory cytokines. New York: John Wiley & Sons, Inc. Chap. 10, p 194-220.
14. Downing JR, Roussel MF, Sherr CJ. 1989. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptors by independent mechanisms. Mol Cell Biol 9:2890-2896.
15. Grandori C, Eisenman RN. 1997. Myc target genes. Trends Biochem Sci 22:177-181.
16. Hamilton JA. 1997. CSF-1 and Cell Cycle Control in Macrophages. Mol Rep Dev 46:19-23.
17. 1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ 7:289-300.
18. Hobeika AC, Subramaniam PS, Johnson HM. 1997. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene 14:1165-1170.
19. Kasten MM, Ayer DE, Stilman DJ. 1997. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol Cell Biol 16:4215-4221.
20. Kimchi A. 1987. Autocrine interferon and the suppression of the c-myc nuclear oncogene. In: Gresser I, editor. Interferon 8. London: Academic Press, Inc. p 85-110.
21. Kimchi A. 1992. Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem 50:1-9.
22. Koskinen PJ, Ayer DE, Eisenman RE. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ 6:623-629.
23. Kuniyasu H, Yasui W, Kitahara K, Naka K, Yokozaki H, Akama Y, Hamamoto T, Tahara H, Tahara E. 1997. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kipl in a human gastric carcinoma cell line. Cell Growth Differ 8:47-52.
24. Laherty CD, Yang WM, Sun JM, Davis JR, Seto E, Eisenman RN. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349-356.
25. Li W, Hack N, Margolis B, Ullrich A, Skarcki K, Schlessinger J. 1991a. Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses. Cell Regul 2:641-649.
26. Li W, Yeung YG, Stanley R. 1991b. Tyrosine phosphorylation of a common 57-kDa protein in growth factor-stimulated and -transformed cells. J Biol Chem 266:6808-6814.
27. Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxil. Proc Natl Acad Sci USA 91:5503-5507.
28. Matsushime H, Roussel M, Ashmun RA, Sherr CJ. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
29. Molecular cloning, a laboratory manual. 1989. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
30. Morgan C, Pollard JW, Stanley ER. 1987. Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5. J Cell Physiol 130: 420-427.
31. Müler M, Briscoe J, Laxton C, Guschin D, Ziemieki A, Silvennoinen O, et al. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366:129-135.
32. Paulus W, Baur I, Boyce FM, Braekefield XO, Reeves SA. 1996. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 70:62-67.
33. Pestka S, Langer JA, Zoon KC, Samuel CE. 1987. Interferons and their actions. Annu Rev Biochem 56:727-777.
34. Renitzky D, Tiefenbrun N, Berissi H, Kimchi A. 1992. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci USA 89:402-406.
35. Rohrschneider LR, Bourette RP, Lioubin MN, Algate PA, Myles GM, Carlberg K. 1997. Growth and differentiation signals regulated by the M-CSF receptor. Mol Reprod Dev 46:96-103.
36. Roussel MF. 1997. Regulation of cell cycle entry and G1 progression by CSF-1. Mol Reprod Dev 46:11-18.
37. Roussel MF, Cleveland JL, Shurtleff SA, Sherr CJ. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signaling. Nature 353:361-363.
38. Roussel ME, Ashmun RA, Sherr CJ, Eisenman RE, Ayer DE. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 16:2796-2801.
39. Schreiber RD, Celada A. 1985. Molecular characterization of interferon gamma as a macrophage activating factor. Lymphokines 11:87-118.
40. Sherr CJ. 1990. Colony-stimulating factor-1 receptor. Blood 75:1-12.
41. Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, Lüscher B. 1997. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 7:357-365.
42. Stanley ER, Chen DM, Lin HS. 1978. Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature 274:168-170.
43. Suai K, Horvath CM, Tsai Huang LH, Qureshi SA, Cowburn D, Darnell JE Jr. 1994. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interaction. Cell 76: 821-828.
44. o-like arrest. Mol Cell Biol 16:3934-3944.
45. Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Stanley ER. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28:71-81.
46. Vadiveloo PK, Vairo G, Novak U, Royston AK, Whitty G, Filonzi EL, Cragoe EG Jr, Hamilton JA. 1996. Differential regulation of cell cycle machinery by vaious antipro-liferative agents is linked to macrophage arrest at distinct G1 checkpoints. Oncogene 13:599-608.
47. van der Geer P, Hunter T. 1993. Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts. EMBO J 12:5161-5172.
48. Vastrik I, Kaipainen A, Penttila TL, Lymboussakis A, Alitalo R, Parvinen M, Alitalo K. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J Cell Biol 128:1197-1208.
49. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, et al. 1993. Nature 366:166-170.